Schwartz wondered if a similar cleavage might be found in GLP-1 (Molteni, Chen)
All animal experiments were approved by the Animal Care and Use Subcommittee at the TCP at Mount Sinai Hospital (Toronto, Canada)
But those studies used oral supplements at specific doses, not transdermal patches
All analyses were conducted with Review Manager, version 5.4 (Nordic Cochrane Centre, Copenhagen, Denmark)
Practical triggers for intervention: Early weight regain (23 kg) Rising hunger/cravings Falling step counts or training adherence Deterioration in glycaemia, BP, or lipids Deprescribing without monitoring is not deprescribing its abandonment
Non-Pharmaceutical Options Lifestyle interventions Structured diet plans, regular physical activity, and behavioural therapy